Mistry, H., Nduka, C., Connock, M., Colquitt, J., Mantopoulos, T., Loveman, E., . . . Mason, J. (2019). Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics.
Citação norma ChicagoMistry, Hema, Chidozie Nduka, Martin Connock, Jill Colquitt, Theodoros Mantopoulos, Emma Loveman, Renata Walewska, and James Mason. "Correction To: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal." Pharmacoeconomics 2019.
Citação norma MLAMistry, Hema, et al. "Correction To: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal." Pharmacoeconomics 2019.